Related Experiment Video
Updated: Aug 10, 2026

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
Published on: May 4, 2017
CBER: new approaches to biological product testing
1Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD 20852-1448, USA.
Abstract:
Biological products are complex molecules and their testing presents unique technical challenges. Furthermore, there are certain expectations for the validation of methods applied for regulatory purposes. A few recent CBER policy initiatives which have an impact on the use of animal tests for biological products will be discussed, followed by an exposé of the MAPREC test for polio virus neurovirulence as an example of alternative test development and the validation process. Finally, some general comments about the validation process will be made.
More Related Videos
Related Concept Videos
Preclinical Development: Overview
Drug Products: Biologics, Biosimilars and Interchangeables
Biological Methods for Microbial Control

